Target intelligence / Profile preview

Solute carrier family 26 member 11 (SLC26A11)

Target
SLC26A11
Molecular classification
Transporter, Anion exchanger, Solute carrier (SLC) family
01

Overview

Solute carrier family 26 member 11 (SLC26A11) is a sodium-independent, DIDS-sensitive anion transporter, primarily mediating the movement of sulfate, bicarbonate, chloride, and oxalate ions across cellular membranes. It is a member of the SLC26 family of anion exchangers that play essential roles in maintaining intracellular electrolyte balance and homeostasis. SLC26A11 is highly expressed in placenta, kidney, and brain, and is thought to facilitate specialized sulfate transport into high endothelial venule endothelial cells, potentially cooperating with SLC26A2. Beyond surface ion exchange, SLC26A11 has emerging importance in lysosomal function and regulation of degradative pathways, suggesting roles in autophagy and cellular clearance as part of the CLEAR network regulated by TFEB. Diseases associated with dysfunction of SLC26A11 include mucopolysaccharidosis IIIA and possibly other lysosomal storage diseases.

Other names
Sodium-independent sulfate anion transporterSolute carrier family 26 (anion exchanger) member 11SLC26A11S2611_HUMAN
02

Mechanism of action

Inhibition of sulfate transport by anion exchanger inhibitors (e.g., DIDS); transport of sulfate, chloride, bicarbonate, oxalate across the membrane

03

Biological functions

Ion homeostasisElectrolyte balanceSulfate transmembrane transportChloride-bicarbonate exchangeLysosomal functionCellular clearance pathwaysAcid secretionRegulation of neuronal activity
04

Disease associations

Mucopolysaccharidosis IIIAMucopolysaccharidosis IIIHereditary hearing loss (genetic localization proximity only)Possibly lysosomal storage disorders
05

Safety considerations

None reported as drug target; genetic proximity to hearing loss loci and expression in multiple tissues may suggest possible systemic effects if inhibited
06

Interacting drugs

4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS)
07

Biomarkers

None explicitly reported; involvement in lysosomal/clearance pathways could make it relevant indirectly as a research biomarker

Beyond the preview

Go deeper on Solute carrier family 26 member 11 (SLC26A11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 26 member 11 (SLC26A11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call